Lenalidomide
Description
Lenalidomide is an immunomodulatory drug used to treat various hematologic malignancies, including multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. It works by modulating the immune system, targeting specific proteins involved in cell growth and survival, and promoting the death of cancerous cells. Lenalidomide is typically administered orally and has shown significant efficacy in improving survival and response rates in patients with these diseases.
Associated Diseases
- Multiple myeloma
- Myelodysplastic syndromes (MDS)
- Mantle cell lymphoma
- Del(5q) myelodysplastic syndromes
- Waldenström macroglobulinemia
- Acute myeloid leukemia (AML)
Did you know?
Lenalidomide was initially developed as an anti-angiogenic drug, but its immunomodulatory properties were later discovered.
